Analytical Data
-
基因名
COLEC10
- Application
-
别名
Collectin liver protein 1 ;CL-L1Collectin-34 ;CL-34
-
种属
Human
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9Y6Z7
-
表达区间
28-277aa
-
分子量
43.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
COLEC10, or Collectin-10, is a member of the collectin family of proteins, which play crucial roles in the innate immune system by recognizing and binding various pathogens. The study of COLEC10 has gained significance due to its involvement in modulating immune responses, particularly in the clearance of microbes and the regulation of inflammation. Research has shown that COLEC10 exhibits specific binding affinity to carbohydrates found on pathogens, thereby facilitating opsonization and promoting phagocytosis by immune cells. The recombinant production of COLEC10 is of great interest for therapeutic applications, as it may enhance immune recognition and response in infectious diseases or even autoimmune disorders. Additionally, understanding COLEC10's structure-function relationship provides insights into its mechanisms of action and potential utility in vaccine development. Given the rising prevalence of infectious diseases and the need for novel immunotherapies, COLEC10 represents a promising avenue for research that may lead to innovative strategies in enhancing host defense mechanisms.
